Preview

Current Pediatrics

Advanced search

Vitamin D Provision in Children with Congenital Epidermolysis Bullosa: Cross-Sectional Study

https://doi.org/10.15690/vsp.v20i5.2315

Abstract

Background. Children with congenital epidermolysis bullosa (CEB) can have vitamin D deficiency due to its malabsorption in intestine and reduced synthesis in skin as these patients have restrictions on staying in the sun. However, the prevalence of vitamin D insufficiency/deficiency among patients with CEB remains not fully studied due to the small samples' sizes in previously studies. Objective. Our aim was to study vitamin D provision in children with CEB. Methods. The study included children aged from 3 to 18 years old with simplex and dystrophic types of CEB hospitalized in our department. The serum level of 25(OH)D was determined via chemiluminescence immunoassay. Vitamin D deficiency was established at 25(OH)D concentration of 20-30 ng/ml, deficiency — < 10-20 ng/ml, deep deficiency — < 10 ng/ml. Results. The study included 129 children with CEB (62 (48%) males, median age 6 (3; 10) years). 101 patients had dystrophic type of disease, 28 — simplex. The median 25(OH)D serum concentration in children with CEB was 21.7 (13.0; 36.6) ng/ml. Vitamin D insufficiency was revealed in 36 (28%) patients, deficiency — in 38 (29%), deep deficiency — in 16 (12%). Independent predictors of 25(OH)D concentration were the type of CEB (concentration was higher in children with simplex type) and age (negative association), but not the patients' gender and the examination season, according to multivariate regression analysis. Conclusion. The study has shown low level of vitamin D provision in children with CEB, whilst 25(OH)D concentration depended on the type of disease and the age of patients.

About the Authors

Irina Yu. Pronina
National Medical Research Center of Children's Health; National Medical Research Center of Endocrinology
Russian Federation

Moscow.


Disclosure of interest:

No conflict of interests.



Nikolay N. Murashkin
National Medical Research Center of Children's Health; Sechenov First Moscow State Medical University (Sechenov University); Central State Medical Academy
Russian Federation

Moscow.


Disclosure of interest:

Nikolay N. Murashkin — receiving research grants from pharmaceutical companies Janssen, Eli Lilly, Novartis. Scientific consultant of Galderma, Pierre Fabre, Bayer, LEO Pharma, Pfizer, AbbVie, Amryt Pharma, Zeldis Pharma.



Svetlana G. Makarova
National Medical Research Center of Children's Health; Lomonosov Moscow State University
Russian Federation

Moscow.


Disclosure of interest:

No conflict of interests.



Elena L. Semikina
National Medical Research Center of Children's Health
Russian Federation

Moscow.


Disclosure of interest:

No conflict of interests.



Dmitry S. Yasakov
National Medical Research Center of Children's Health
Russian Federation

Moscow.


Disclosure of interest:

No conflict of interests.



Stepan G. Grigoriev
Pediatric Research and Clinical Center for Infectious Diseases
Russian Federation

Saint Petersburg.


Disclosure of interest:

No conflict of interests.



References

1. Bardhan A, Bruckner-Tuderman L, Chapple I, et al. Epidermolysis bullosa. Nat Rev Dis Primers. 2020;6(1):78. doi: 10.1038/s41572-020-0210-0

2. Bulleznyi epidermoliz: Guide for doctors. Murashkin NN, Namazova-Baranova LS, eds. Moscow: Pediatr; 2019. 444 p. (In Russ).

3. Fine JD, Bruckner-Tuderman L, Eady RAJ, et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol. 2014;70(6):1103-1126. doi: 10.1016/j.jaad.2014.01.903

4. Fine JD. Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the National Epidermolysis Bullosa Registry. JAMA Dermatol. 2016;152(11):1231-1238. doi: 10.1001/jamadermatol.2016.2473

5. Has C, Bauer JW, Bodemer C, et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br J Dermatol. 2020;183(4):614-627. doi: 10.1111/bjd.18921

6. Mariath LM, Santin JT, Schuler-Faccini L, Kiszewski AE. Inherited epidermolysis bullosa: update on the clinical and genetic aspects. An Bras Dermatol. 2020;95(5):551-569. doi: 10.1016/j.abd.2020.05.001

7. Albanova VI, Smolyannikova VA, Golchenko VA. Kindler syndrome — a rare type of hereditary epidermolysis bullosa. Vestnik Dermatologii i Venerologii. 2015;(4):95-104. (In Russ).

8. Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues. J Am Acad Dermatol. 2009;61(3):367-384. doi: 10.1016/j.jaad.2009.03.052

9. Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs. J Am Acad Dermatol. 2009;61(3):387-402. doi: 10.1016/j.jaad.2009.03.053

10. Murashkin NN, Makarova SG, Epishev RV, et al. Assessment of nutritional imbalance in children with epidermolysis bullosa. Kremlin Medicine Journal. 2018;(1):61-65. (In Russ).

11. Reyes ML, Cattani A, Gajardo H, et al. Bone metabolism in children with epidermolysis bullosa. J Pediatr. 2002;140(4):467-469. doi: 10.1067/mpd.2002.123287

12. Salera S, Tadini G, Rossetti D, et al. A nutrition-based approach to epidermolysis bullosa: Causes, assessments, requirements and management. Clin Nutr. 2020;39(2):343-352. doi: 10.1016/j.clnu.2019.02.023

13. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academy Press; 2010.

14. Cranney C, Horsely T, O'Donnell S, et al. Effectiveness and safety of vitamin D. Evid Rep Technol Asses (Full Rep). 2007;(158):1-235.

15. Pludowski P, Holick MF, Pilz S, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev. 2013;12(10):976-989. doi: 10.1016/j.autrev.2013.02.004

16. Martinez AE, Mellerio JE. Osteopenia and osteoporosis in epidermolysis bullosa. Dermatol Clin. 2010;28(2):353-355. doi: 10.1016/j.det.2010.01.006

17. Varki R, Sadowski S, Uitto J, Pfendner E. Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes. J Med Genet. 2007;44(3):181-192. doi: 10.1136/jmg.2006.045302

18. Vahidnezhad H, Youssefian L, Zeinali S, et al. Dystrophic Epidermolysis Bullosa: COL7A1 Mutation Landscape in a Multi-Ethnic Cohort of 152 Extended Families with High Degree of Customary Consanguineous Marriages. J Invest Dermatol. 2017;137:660-669. doi: 10.1016/j.jid.2016.10.023

19. Rodari G, Guez S, Manzoni F, et al. Birmingham epidermolysis severity score and vitamin D status are associated with low BMD in children with epidermolysis bullosa. Osteoporos Int. 2017;28(4):1385-1392. doi: 10.1007/s00198-016-3883-1

20. Makarova SG, Namazova-Baranova LS, Murashkin NN, et al. Correction of Nutritional Status in Complex Therapy for Children Suffering from Dystrophic Forms of Innate Epidermolysis Bullosa. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2016;13(6):577-586. (In Russ). doi: 10.15690/pf.v13i6.1672

21. Reimer A, Hess M, Schwieger-Briel A, et al. Natural history of growth and anaemia in children with epidermolysis bullosa: a retrospective cohort study. Br J Dermatol. 2020;182(6):1437-1448. doi: 10.1111/bjd.18475

22. Epishev RV. Nutritivnaya podderzhka detei s vrozhdennym bulleznym epidermolizom. [dissertation]. Moscow; 2018. (In Russ).

23. Fine JD, Tamura T, Johnson L. Blood vitamin and trace metal levels in epidermolysis bullosa. Arch Dermatol. 1989;125:374-379.

24. Ingen-Housz-Oro S, Blanchet-Bardon C, Vrillat M, Dubertret L. Vitamin and trace metal levels in recessive dystrophic epidermolysis bullosa. J Eur Acad Dermatol Venereol. 2004;18(6):649-653. doi: 10.1111/j.1468-3083.2004.01067.x

25. Petrushkina AA, Pigarova EA, Rozhinskaya LYa. The prevalence of vitamin D deficiency in Russian Federation. Osteoporosis and Bone Diseases. 2018;21(3):15-20. (In Russ). doi: 10.14341/osteo10038

26. Natsional'naya programma “Nedostatochnost' vitamina D u detei i podrostkov Rossiiskoi Federatsii: sovremennye podkhody k korrektsii”. Moscow: Pediatr; 2018. 96 p. (In Russ).


Review

For citations:


Pronina I.Yu., Murashkin N.N., Makarova S.G., Semikina E.L., Yasakov D.S., Grigoriev S.G. Vitamin D Provision in Children with Congenital Epidermolysis Bullosa: Cross-Sectional Study. Current Pediatrics. 2021;20(5):407-412. https://doi.org/10.15690/vsp.v20i5.2315

Views: 506


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)